Samsung Biologics to add mRNA vaccine drug substance manufacturing suite to expand portfolio ...

Retrieved on: 2021-05-31 10:52:30

Tags for this article:

Companies

Industry economics)

Life Sciences

Pharmaceutical industry

Samsung

Samsung Biologics

Contract manufacturing organization

Biopharmaceutical

WuXi Biologics

Samsung Biologics Co., Ltd.

207940.KS

Click the tags to see associated articles and topics

Samsung Biologics to add mRNA vaccine drug substance manufacturing suite to expand portfolio .... View article details on hiswai:

Excerpt

mRNA has been the technology of choice for many COVID-19 vaccines due to its characteristics of safety, and fast scalability in manufacturing. Samsung ...

Article found on: www.prnewswire.com

View Original Article